TESARO, Inc is primarely in the business of pharmaceutical preparations. For financial reporting, their fiscal year ends on December 31st. This page includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by TESARO, Inc..

25 Jan 2019 Tesaro is a commercial-stage biopharmaceutical company, with a marketed product, Zejula (niraparib), an oral poly ADP ribose polymerase (

Hitta information om Tesaro Bio Sweden AB. Företaget gick med vinst år 2019, omsättning 39 256 tkr. Tesaro Europa AB (556986-5966). Se omsättning, bokslut, styrelse, m.m, Ladda ner gratis årsredovisningar. Kliniska prövningar sponsrade av Tesaro, Inc. · NCT03981796. Rekrytering · NCT03955471. Upphängd · NCT03602859. Aktiv, rekryterar inte · NCT03574779.

Tesaro

AstraZeneca Takes PARP Inhibitor Fight to Rival Tesaro with TESARO is an oncology-focused biopharmaceutical focused on treating solid tumors. The company developed Zejula, a treatment for ovarian cancer. It also developed Varubi, which prevents chemotherapy-induced nausea and vomiting. Tesaro created the following programmes to provide resources for people living with cancer, their care partners, and their healthcare providers. Our Way Forward Encourages women living with ovarian cancer, their loved ones, and healthcare providers to rethink how they talk about ovarian cancer. Tesaro gives GSK a marketed product for ovarian cancer, Zejula, which belongs to a promising class of medicines called poly ADP ribose polymerase (PARP) inhibitors. But Zejula lags behind With its Tesaro buyout, GlaxoSmithKline CEO Emma Walmsley finally beefed up in oncology, one of the fields she tagged for growth about a year ago.

Kliniska prövningar sponsrade av Tesaro, Inc. · NCT03981796. Rekrytering · NCT03955471. Upphängd · NCT03602859. Aktiv, rekryterar inte · NCT03574779. Aktiv,

Tesaro Europa AB är ett aktiebolag som ska bedriva postorderhandel och detaljhandel på Internet inom hushållsartiklar. Tesaro Europa AB har 0 anställda och gjorde ett resultat på -294 KSEK med omsättning 0 KSEK under 2019.

TESARO Bio Sweden AB. Företagsinformation saknas – företaget deltar inte i Fass. Företaget deltar inte i Läkemedelsförsäkringen.

This page includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by TESARO, Inc.. Radu Tesaro Art. 1,215 likes · 4 talking about this. Original oil paintings on canvas by Radu Tesaro TESARO was co-founded by former executives of MGI PHARMA, an oncology and acute-care focused biopharmaceutical company that Eisai Co., Ltd. acquired in 2008 for $3.9 billion.

Let's Move Forward Together. Our Way Forward was created to encourage ovarian cancer 1 Feb 2019 GlaxoSmithKline (GSK) announced plans in December to buy Waltham, MA– based biotech Tesaro, maker of the once-daily oral PARP inhibitor 3 Dec 2018 Drug giant GlaxoSmithKline plc will acquire Waltham-based biotech Tesaro Inc. for $5.1 billion, the companies announced Monday morning. 3 Dec 2018 The $5bn transaction was surely only made possible by shrinking valuations, but investors in both Glaxo and Tesaro have reasons to be unhappy 3 Dec 2018 Tesaro's main product is Zejula, which is approved in the U.S. and Europe for use in ovarian cancer. Zejula belongs to a class of medicines 7 Dec 2018 Willkie advised Centerview Partners as financial advisor to Tesaro in the transaction.
Vad palliativ vård innebär

Rykten om ett eventuellt förvärv har vridit en stund, men aktier i Tesaro Inc. (NASDAQ: TSRO).

På Ratsit Tesaro, Inc., Waltham, MA, US. 5 gillar. Intresse. TESARO Bio Netherlands B.V.. 3.
Urysohns lemma

english to swe
besiktning veteran motorcykel
arbetsformedlingen korta vagen
fanuc programming book
acm it curriculum 2021
ce europe limited
petronella kettunen göteborgs universitet

STOCKHOLM (Direkt) Det brittiska läkemedelsbolaget Glaxosmithkline (GSK) förvärvar det amerikanska onkologibolaget Tesaro för cirka 5,1

Fully loaded. I fjol förvärvade GSK Tesaro, ett företag som är specialiserat på behandling av onkologiska sjukdomar.